Related Experiment Video
Updated: Aug 19, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Coronary artery vasospasm causing acute myocardial infarction in a heart transplant recipient
John D Bisognano1, Joann Lindenfeld, Elizabeth Hammond
1University of Rochester Medical Center, Rochester, New York, NY, USA.
Insights
Cardiac allograft vasculopathy may involve reversible coronary artery vasospasm. This case study highlights abnormal vasoreactivity as an early, potentially reversible stage of cardiac allograft vasculopathy.
Area of Science:
- Cardiology
- Transplant Immunology
- Vascular Biology
Background:
- Cardiac allograft vasculopathy (CAV) etiology remains unclear, potentially involving endothelial and smooth muscle dysfunction.
- CAV is a major cause of long-term graft failure after heart transplantation.
Observation:
- A heart transplant recipient experienced acute myocardial infarction due to coronary artery vasospasm.
- The patient had a history of severe vascular rejection post-transplant.
- Chest pain, a rare symptom in denervated hearts, prompted early diagnosis.
Findings:
- The myocardial infarction was attributed to acute, reversible coronary artery vasospasm.
- This event occurred months after severe vascular rejection, suggesting a link.
Implications:
- This case supports the hypothesis that early-stage CAV may present with reversible vasoreactivity abnormalities.
- Understanding vasoreactivity is crucial for managing and potentially preventing CAV progression.
- Early detection of vasospasm could offer therapeutic opportunities in heart transplant recipients.
Abstract:
The etiology of cardiac allograft vasculopathy is not known, but may be preceded by both endothelial cell and smooth muscle dysfunction of the epicardial coronary arteries. We here report a case of acute, reversible coronary artery vasospasm which caused a myocardial infarction in a cardiac transplant recipient. The patient had a complex post-transplant course, including an episode of severe vascular rejection several months before this presentation. Interestingly, the event was captured in its early stages because the patient presented with chest pain: a rare event because of the denervation of the transplanted heart. Our ability to document the etiology of this patient's myocardial infarction supports the concept that cardiac allograft vasculopathy is a progressive disease that, in its early stages, may include a reversible component of abnormal vasoreactivity.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis I: Introduction
Coronary Artery Disease III: Clinical Manifestations
